US Patent Issued to HUYABIO International on Nov. 11 for "Sulcardine administration for treatment of acute atrial fibrillation" (California Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,587, issued on Nov. 11, was assigned to HUYABIO International LLC (San Diego).

"Sulcardine administration for treatment of acute atrial fibrillation" was invented by Gary Elliott (San Diego), Mireille Gillings (San Diego), Robert Goodenow (San Diego), Jay Mason (San Diego), Waldemar Radziszewski (San Diego) and Suzanne Romano (San Diego).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are compositions and methods for administration of sulcardine to a subject in need thereof."

The patent was filed on Oct. 11, 2023, under Application No. 18/484,823.

*For further information, including images, charts and tables, please visit: http://pat...